| Literature DB >> 31217090 |
Kyungho Yoon1, Wonhye Lee1, Emily Chen1, Ji Eun Lee1, Phillip Croce1, Amanda Cammalleri1, Lori Foley2, Allison L Tsao3, Seung-Schik Yoo4.
Abstract
Transcranial application of focused ultrasound (FUS) combined with vascular introduction of microbubble contrast agents (MBs) has emerged as a non-invasive technique that can temporarily create a localized opening in the blood-brain barrier (BBB). Under image-guidance, we administered FUS to sheep brain after intravenous injection of microbubbles. BBB opening was confirmed by performing dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to detect the extravasated gadolinium-based magnetic resonance contrast agents. Through pharmacokinetic analysis as well as independent component analysis of the DCE-MRI data, we observed localized enhancement in BBB permeability at the area that subjected to acoustic pressure of 0.48 MPa (mechanical index = 0.96). On the other hand, application of a higher pressure at 0.58 MPa resulted in localized, minor cerebral hemorrhage. No animals exhibited abnormal behavior during the post-FUS survival periods up to 2 mo. Our data suggest that monitoring for excessive BBB disruption is important for safe translation of the method to humans.Entities:
Keywords: Blood–brain barrier; Drug delivery; Dynamic contrast-enhanced magnetic resonance imaging; Focused ultrasound; Independent component analysis; Pharmacokinetics
Year: 2019 PMID: 31217090 PMCID: PMC6693666 DOI: 10.1016/j.ultrasmedbio.2019.05.023
Source DB: PubMed Journal: Ultrasound Med Biol ISSN: 0301-5629 Impact factor: 2.998